MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
SBC

SBC

SBC Medical Group Holdings Incorporated

$2.99
0.03
 (1.01%)
Exchange:  NASDAQ
Market Cap:  307.512M
Shares Outstanding:  15.067M
Delayed data
Calculate SBC Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Industrials
Industry:  Consulting Services
   
CEO:  Yoshiyuki Aikawa
Full Time Employees:  863
Address: 
200 Spectrum Center Drive
Irvine
CA
92618
US
Website:  https://sbc-holdings.com
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group’s supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue193,542.423205,415.542173,607.489
Gross Profit137,304.038156,050.507127,283.722
EBITDA85,871.56977,283.49984,910.513
Operating Income70,660.06670,303.71067,486.398
Net Income39,370.03646,614.27550,985.613

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets258,805.271266,083.153380,447.946
Total Liabilities114,995.02271,060.996117,143.240
Total Stockholders Equity142,159.177195,109.156248,282.196
Total Debt22,866.48912,214.14351,636.174
Cash and Cash Equivalents103,022.932125,044.092163,773.838

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow50,643.54220,582.93338,920.998
Capital Expenditure-11,207.948-3,408.383-2,369.858
Free Cash Flow39,435.59417,174.55036,551.140
Net Income39,370.03646,614.27550,985.613
Net Change in Cash51,284.93822,021.16038,729.746

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)189,745Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)205,255Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)197,500Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)70,167.581Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)75,903.169Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)73,035.375Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)49,959.164Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)52,632.991Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)51,300Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)74,221.390Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)80,288.341Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)77,254.865Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.500Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.510Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.490Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
205.416M  ?P/S
 (TTM)
: 
1.83
?Net Income
 (TTM)
: 
46.614M  ?P/E
 (TTM)
: 
7.57
?Enterprise Value
 (TTM)
: 
162.716M  ?EV/FCF
 (TTM)
: 
3.69
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
?ROE
 (TTM)
: 
  ?ROIC
 (TTM)
: 
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
?P/B
 (TTM)
: 
  ?Current Ratio
 (TTM)
: 

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates SBC intrinsic value between $2.62 – $2.79 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about SBC valuation

Is SBC (SBC) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for SBC (SBC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SBC a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SBC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is SBC’s P/E ratio?

You can see SBC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for SBC?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is SBC a good long-term investment?

Whether SBC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

SBC

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.01
MARKETSnap

Trading Metrics:

Open: —   Previous Close: —
Day Low: —   Day High: —
Year Low:    Year High: 
Price Avg 50:    Price Avg 200: 
Volume:    Average Volume: 

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
Analyzing SBC Medical Group (NASDAQ:SBC) and Solventum (NYSE:SOLV)
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
SBC Medical Group (NASDAQ:SBC) Stock Price Up 0.7%  – Time to Buy?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read